Skip to content
  • Sunday, 26 July 2026
  • 2:57 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Humanity’s African Origins: A Sweeping Genetic Analysis Unveils a Complex Network, Not a Single Source
Molecular & Cell Biology

Humanity’s African Origins: A Sweeping Genetic Analysis Unveils a Complex Network, Not a Single Source

Angie Faith May 25, 2026 0

A groundbreaking genetic analysis, published in the prestigious journal Nature in 2023, is fundamentally reshaping our understanding of human origins.…

Read More
Molecular & Cell Biology

A Sweeping Genetic Analysis Reshapes the Narrative of Human Origins, Revealing a Complex African Network

Angie Faith May 11, 2026 0

A groundbreaking genetic analysis published in 2023 has significantly challenged the long-held, simplified narrative of human origins, which posited that…

Read More
Molecular & Cell Biology

A Sweeping Genetic Analysis Challenges the Single Ancestral Population Theory of Human Origins

Angie Faith May 3, 2026 0

The long-held narrative of human origins, suggesting a singular ancestral population in Africa as the sole source of all modern…

Read More
Molecular & Cell Biology

A Sweeping Genetic Analysis Challenges Single-Origin Theory, Revealing a Complex Tapestry of Human Ancestry in Africa

Angie Faith Apr 26, 2026 0

A groundbreaking genetic analysis, published in the prestigious journal Nature in 2023, is compelling scientists to re-evaluate fundamental assumptions about…

Read More
Clinical Diagnostics & Pathology

CMS Seeks Lab Input on Sweeping Anti-Fraud Rules Targeting Genetic Testing Overspending

Reynand Amr Wu Apr 10, 2026 0

With genetic test spending under the microscope, CMS is asking labs to help shape future anti-fraud rules—before formal proposals are…

Read More
Clinical Diagnostics & Pathology

CMS Launches Sweeping Anti-Fraud Initiative, Targeting Genetic Testing Spending and Soliciting Lab Industry Input for Future Regulations

Reynand Amr Wu Mar 26, 2026 0

The Centers for Medicare and Medicaid Services (CMS) has embarked on a significant preemptive strike against healthcare fraud, initiating a…

Read More
University of Illinois Researchers Discover Glycan-Based Method to Extend Sperm Viability and Improve IVF Success RatesNew Blood Test Paradigm for Alzheimer’s Disease Detection Focuses on Protein Structure Rather Than ConcentrationThe Human Body: A Map Still Being DrawnGenetic Research Unveils Two Distinct Species of Leaf Warbler in Japan, Highlighting Hidden Biodiversity
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ